Home » Topics » Briefs » Other news to note

Other news to note
RSS

Ikaria to in-license worldwide rights to investigational fibrin-derived peptides

Aug. 13, 2009

Shareholders of Schering-Plough approve proposed merger with Merck & Co.

Aug. 12, 2009

Nanotherapeutics updates clinical progress of NanoBUP and NanoDOX

Aug. 11, 2009

Eden and Omnio sign agreement for production of protein candidate for wound healing

Aug. 11, 2009

Alnylam and Tekmira enter research collaboration for systemic delivery of RNAi therapeutics

Aug. 11, 2009

Anesiva and Arcion Therapeutics sign definitive merger agreement

Aug. 10, 2009

AlphaRx and Venturepharm sign agreement for drug development center in China

Aug. 10, 2009

Laboratory Corporation acquires Monogram Biosciences pursuant to cash tender offer

Aug. 10, 2009

MSM and Merck Serono collaborate to create antibody-based products targeted to GPCRs

Aug. 5, 2009

Organon and Ligand mutually terminate December 2008 collaboration and license agreement

Aug. 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...